H2APEX Group (H2A) Fair Value & Analysis
Basic Materials · DE · Market cap €49.9M
Fair value as of: Jun 25, 2026
Analysis
H2APEX Group (H2A) currently trades at €0.8780, while our model-based Fair Value estimate is €0.8135 — implying the stock looks roughly 7.3% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
H2APEX Group SCA develops, manufactures, and operates green hydrogen plants for the de-carbonization of industry and infrastructure in Germany and Luxembourg. It operates through Operations, Project Development, and Storage segments. The Operations segment includes production and selling of green hydrogen, as well as the derivatives electricity and heat generation. The Project Development segment comprises work related to project development and system integration for third-party hydrogen plants, as well as turnkey solutions for the supply of hydrogen are modular, tech-agnostic, and tailor-made. The Storage segment includes development and manufacturing of different hydrogen storage systems. It serves transportation and logistics, industry, engineering office, research, government, and automobile manufacturer sectors. H2APEX Group SCA was founded in 2000 and is headquartered in Rostock, Germany.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is H2APEX Group (H2A) undervalued?
What is the fair value of H2A?
What is the quality score of H2A?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.